Krystexxa
Product Images NDC 54396-801

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Krystexxa (NDC 54396-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Savient Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Krystexxa-01 (Krystexxa 01)

Packaging label for Krystexxa (pegloticase) Injection 8 mg/mL by Savient Pharmaceuticals, Inc. The label states it is for intravenous infusion in a single-use vial and includes instructions to discard unused portions and to dilute prior to administration. The label emphasizes dispensing the enclosed Medication Guide to each patient and includes storage instructions and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.